PI Industries Limited (PIIND)

Chemicals · Fertilizers & Agrochemicals · NSE · Updated 2 August 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹2,751.2 ↓ 35.28% (1Y)

🎯 Key Takeaways

PI Industries is in a strategic transition phase, evolving from a traditional agrochemical player into a global life sciences innovator with a focus on biologicals, CRDMO, and electronic chemicals. Despite near-term revenue headwinds, the company maintains strong profitability, a debt-free balance sheet, and robust cash surplus, underpinned by sustained R&D investment and ESG leadership.
Revenue declined 14.4% QoQ to ₹1,901 in Q3FY25.
⚠️ Persistent revenue decline in core agrochemical segments poses near-term earnings volatility, despite margin resilience.

Market Cap

₹47,259

P/E Ratio

27.8

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About PIIND 📊 Interactive Charts

📖 The Story

PI Industries is in a strategic transition phase, evolving from a traditional agrochemical player into a global life sciences innovator with a focus on biologicals, CRDMO, and electronic chemicals. Despite near-term revenue headwinds, the company maintains strong profitability, a debt-free balance sheet, and robust cash surplus, underpinned by sustained R&D investment and ESG leadership. Management views this transformation as a long-term value driver, aligning with global sustainability and innovation trends.

📰 What's Happening

In the latest developments, PI Industries announced the conversion of ₹70 billion in unlisted OFCDs by its subsidiary Pl Health Sciences Limited into equity shares, strengthening the consolidated balance sheet without altering ownership. The company also scheduled its 79th AGM for August 14, 2026, via video conferencing, with a record date of August 7, 2026, for a proposed final dividend of Rs. 10 per share. Shareholders must update their email registrations to receive electronic notices and reports. Additionally, the company emphasized its sustainability transformation, targeting 40% renewable electricity, 30% renewable energy, 20% GHG intensity reduction, 50% water neutrality, and 91% waste circularity by FY 2031, alongside expanding biologicals revenue fivefold and commercializing Pioxaniliprole.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	1,566	1,910	2,117	1,898	1,741	2,069	2,221	1,901
Operating Profit	392	515	598	610	500	656	750	588
OPM %	21.9%	24.5%	26.1%	29.2%	25.4%	28.2%	28.3%	26.9%
Net Profit	281	383	481	449	370	449	508	373
EPS	₹18.49	₹25.24	₹31.67	₹29.59	₹24.36	₹29.59	₹33.51	₹24.55

Quarterly revenue has shown a clear downward trend, declining from ₹2,117 million in Q2FY24 to ₹1,901 million in Q3FY25, with a peak in Q2FY25 followed by sequential softness. However, operating performance remains resilient, with OPM holding steady around 26-28% despite lower volumes, indicating effective cost management. Net profit and EPS have also declined from highs of ₹508 million and ₹33.51 in Q2FY25 to ₹373 million and ₹24.55 in Q3FY25, reflecting the revenue contraction but stable margins. This suggests that while top-line pressure persists, operational efficiency is being maintained, likely supported by product mix optimization and cost discipline.

🔮 Management Outlook & What's Next

Management has articulated an ambitious long-term vision through the FY2025-26 Integrated Annual Report, targeting significant sustainability milestones by FY 2031, including 40% renewable electricity, 30% renewable energy, 20% GHG intensity reduction, 50% water neutrality, and 91% waste circularity. It also aims to expand biologicals revenue fivefold, commercialize Pioxaniliprole, and maintain a balanced dividend policy. These goals are supported by ongoing investments in R&D (₹3,556 million) and strategic expansion into high-growth areas like CRDMO and electronic chemicals, positioning the company as a global life sciences innovator with a strong ESG foundation.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Fertilizers & Agrochemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Fertilizers and Chemicals Travancore Limited	57,117	-630.5	—	—	—
Coromandel International Limited	55,044	33.3	—	—	—
UPL Limited	53,373	-157.3	—	—	—
PI Industries Limited	47,259	27.8	—	—	—
Sumitomo Chemical India Limited	22,898	44.4	—	—	—
Bayer Cropscience Limited	21,796	—	—	—	—
Chambal Fertilizers & Chemicals Limited	18,025	11.1	—	—	—
Paradeep Phosphates Limited	12,506	30.3	—	—	—
Sharda Cropchem Limited	8,742	35.8	—	—	—
Rashtriya Chemicals and Fertilizers Limited	6,876	25.9	—	—	—

🔗 Peer Stock Analyses

FACT COROMANDEL UPL SUMICHEM BAYERCROP

⚠️ Risk Factors

1. Persistent revenue decline in core agrochemical segments poses near-term earnings volatility, despite margin resilience. 2. Execution risk in scaling biologicals and CRDMO businesses to achieve fivefold growth and commercialize Pioxaniliprole, which requires sustained R&D and market adoption. 3. Sustainability targets are ambitious and time-bound; failure to meet FY 2031 goals could impact ESG credibility and investor perception. 4. Regulatory and market risks in global life sciences and electronic chemicals segments, including compliance and supply chain dynamics, could affect international expansion.

📋 Recent Filings

🧠 Analyst's Read

PI Industries is navigating a pivotal transformation from a traditional agrochemical firm to a global life sciences innovator, supported by strong financials, ESG leadership, and strategic R&D investments. While near-term revenue softness is evident, the company's resilience in margins, debt-free status, and clear long-term roadmap provide stability. Investors should monitor the pace of biologicals growth, execution of sustainability targets, and capital allocation discipline, particularly regarding dividend sustainability and expansion into high-margin segments.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on PIIND

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-02.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PIIND files new disclosures

Track PIIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PIIND — Free

Free account · 2 AI queries/day